好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Acute Leukoencephalopathies

Saturday 04/24/04
06:00 PM - 08:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Kick-Off Program
Claudia F. Lucchinetti, MD, FAAN
Neurogenetics/Neurometabolic Disorders/Neurotoxicology
Upon completion:
Participants should be able to propose a plan to investigate and manage patients with acute leukoencephalopathies; appreciate the spectrum of the inflammatory demyelinating diseases that may present as an acute leukoencephalopathy; and appreciate the role of the brain biopsy and neuropathology in the investigation and diagnosis of these disorders.
No CME available
Advanced
Practitioner, Fellow, Academician
Event Timeline
06:00 PM - 08:00 PM Acute Leukoencephalopathies
Claudia F. Lucchinetti, MD, FAAN, Joseph E. Parisi, MD, Brian G. Weinshenker, MD, FAAN
Faculty Disclosures
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.